WASHINGTON, DC – Investigators with the IMPROVE (IMPact on Revascularization Outcomes of intraVascular ultrasound guided treatment of complex lesions and Economic impact) trial announced that the first patient was enrolled Friday, October 16, 2020, at MedStar Washington Hospital Center, Washington, DC.